Status:
UNKNOWN
Attention and Pain in Children With and Without Attention Deficit and/or Hyperactivity Disorder
Lead Sponsor:
Université de Sherbrooke
Conditions:
Attention Deficit Disorder With Hyperactivity
Placebo Effect
Eligibility:
All Genders
8-9 years
Phase:
NA
Brief Summary
In Quebec, there has been an important increase of Attention Deficit Hyperactivity Disorder (ADHD) diagnosis since 2015. ADHD symptoms, related to behavioural and/or concentration difficulties, are ve...
Detailed Description
Attention Deficit with or without Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that affects 2 to 7% worldwide youth population and 6.2% of children aged 6 to 11 years in Quebec \[1-3...
Eligibility Criteria
Inclusion
- Child 8 or 9 years old
- ADHD diagnosis confirmed by a qualified health professional (for the ADHD group only).
- Understand French
Exclusion
- Other neurological problems other than ADHD
- Diagnosis of a psychological disorder
- Intellectual disability
Key Trial Info
Start Date :
February 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04766580
Start Date
February 17 2021
End Date
June 30 2023
Last Update
July 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche sur le vieillissement (CdRV)
Sherbrooke, Quebec, Canada, J1H 4C4